0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Original Investigation |  ONLINE FIRST
Ole Köhler, MD; Michael E. Benros, PhD; Merete Nordentoft, PhD; et al.
JAMA Psychiatry. Published online October 15, 2014. doi:10.1001/jamapsychiatry.2014.1611
Includes: Supplemental Content

Original Investigation | 
Lee M. Hampton, MD, MSc; Matthew Daubresse, MHS; Hsien-Yen Chang, PhD; et al.
JAMA Psychiatry. 2014;71(9):1006-1014. doi:10.1001/jamapsychiatry.2014.436.
Includes: Supplemental Content

Original Investigation | 
Theodore J. Cicero, PhD; Matthew S. Ellis, MPE; Hilary L. Surratt, PhD; et al.
JAMA Psychiatry. 2014;71(7):821-826. doi:10.1001/jamapsychiatry.2014.366.
Includes: CME

Viewpoint | 
Ian R. H. Rockett, PhD, MPH; Nestor D. Kapusta, MD; Jeffrey H. Coben, MD
JAMA Psychiatry. 2014;71(3):231-232. doi:10.1001/jamapsychiatry.2013.3738.

Original Investigation |  FREE
William V. Bobo, MD, MPH; William O. Cooper, MD, MPH; C. Michael Stein, MB, ChB; et al.
JAMA Psychiatry. 2013;70(10):1067-1075. doi:10.1001/jamapsychiatry.2013.2053.
Includes: Supplemental Content

Original Investigation |  FREE
Giuseppe Blasi, MD, PhD; Caterina De Virgilio, PhD; Apostolos Papazacharias, MD; et al.
JAMA Psychiatry. 2013;70(9):921-930. doi:10.1001/jamapsychiatry.2013.1378.
Includes: Supplemental Content

Original Investigation |  FREE
Kathryn L. Humphreys, MA, EdM; Timothy Eng, BS; Steve S. Lee, PhD
JAMA Psychiatry. 2013;70(7):740-749. doi:10.1001/jamapsychiatry.2013.1273.
Includes: Supplemental Content

Original Article |  FREE
Andrew E. Timms, PhD; Michael O. Dorschner, PhD; Jeremy Wechsler, MS; et al.
JAMA Psychiatry. 2013;70(6):582-590. doi:10.1001/jamapsychiatry.2013.1195.
Includes: Supplemental Content

Editorial | 
Kenneth Silverman, PhD; Anthony DeFulio, PhD; Jeannie-Marie Leoutsakos, PhD
JAMA Psychiatry. 2013;70(6):571-572. doi:10.1001/jamapsychiatry.2013.1116.

Original Article |  FREE
Eugene C. Somoza, MD, PhD; Douglas Winship, BS; Charles W. Gorodetzky, MD, PhD; et al.
JAMA Psychiatry. 2013;70(6):630-637. doi:10.1001/jamapsychiatry.2013.872.
Includes: Supplemental Content

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Subscribe to the journal
From The JAMA Network
JAMA Internal Medicine
Invited Commentary  | 
Finding Meaningful Patterns in Adverse Drug Event Reports
Joshua J. Gagne, PharmD, ScD
JAMA Internal Medicine
Invited Commentary  | 
Dopamine Receptor Agonist Drugs and Impulse Control Disorders
Howard D. Weiss, MD; Gregory M. Pontone, MD
JAMA Internal Medicine
Original Investigation  | 
Reports of Pathological Gambling, Hypersexuality, and Compulsive Shopping Associated With Dopamine Receptor Agonist Drugs
Thomas J. Moore, AB; Joseph Glenmullen, MD; Donald R. Mattison, MD, MS
JAMA Dermatology
Case Report/Case Series  | 
Drug-Associated Dermatomyositis Following Ipilimumab Therapy:  A Novel Immune-Mediated Adverse Event Associated With Cytotoxic T-Lymphocyte Antigen 4 Blockade
Shirwa Sheik Ali, BSc; Allison L. Goddard, MD; Jason J. Luke, MD; et al.